The levels of anti-HPV16/18 and anti-HPV31/33/35/45/52/58 antibodies among AS04-adjuvanted HPV16/18 vaccinated and non-vaccinated Ugandan girls aged 10-16 years.

Nakalembe, Miriam; Banura, Cecily; Namujju, Proscovia B; Mirembe, Florence M

Nakalembe, Miriam; Banura, Cecily; Namujju, Proscovia B; Mirembe, Florence M.

Afiliación

Nakalembe M; Department of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda.
Banura C; Department of Child Health and Development Center, Makerere University, Kampala, Uganda.
Namujju PB; Department of Children's, Adolescent's and Adult's Health, National Institute for Health and Welfare, Oulu, Finland ; School of Health Sciences, University of Tampere, Tampere, Finland.
Mirembe FM; Department of Obstetrics and Gynaecology, Makerere University, Kampala, Uganda.

Infect Agent Cancer ; 9: 29, 2014.

Article en En | MEDLINE | ID: mdl-25206925

Palabras clave

Adolescents; Bivalent HPV vaccine; Human Papilloma Virus; Immune response; Uganda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Infect Agent Cancer Año: 2014 Tipo del documento: Article País de afiliación: Uganda

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google